Search
for
Sort by
Research 421–450 of 1000+
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: A single-center retrospective cohort study
- Para rubber seed oil: The safe and efficient bio‐material for hair loss treatment
- Frontal fibrosing alopecia
- Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: A Review.
- 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Theoretical evaluation of interaction of some dibenzo derivatives on both androgen receptor and 5α-reductase enzyme
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Frontal fibrosing alopecia: A multicenter review of 355 patients
- Hyperpigmentation following Treatment of Frontal Fibrosing Alopecia
- Blood donors on teratogenic drugs and donor deferral periods in a clinical situation
- Pathogenetic justification of the use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia.
- Frontal edema due to mesotherapy for androgenetic alopecia: A case series
- The connection of 5-alpha reductase inhibitors to the development of depression
- Finasteride for hair loss: a review
- Dermatologic Care of Hair in Transgender Patients: A Systematic Review of Literature
- The Latest Trends of Treatment for Alopecia
- Identification of 5α-reductase isoenzymes in canine skin
- Off-label prescriptions: patient safety first
- The Benefits of Dual Inhibition of 5α Reductase
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Theoretical Evaluation of Twenty-Cannabinoid Derivatives on Either Androgen Receptor or 5α-Reductase Enzyme
- Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle
- The inflammatory component of androgenetic alopecia
- Extraordinary claims without extraordinary evidence: controversy on anti‐androgen therapy for COVID‐19
- Development of a Liquid Chromatography/Mass Spectrometry-Based Inhibition Assay for the Screening of Steroid 5-α Reductase in Human and Fish Cell Lines
- Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide